These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 35333997)
1. Uremic toxin indoxyl sulfate induces dysfunction of vascular smooth muscle cells via integrin-β1/ERK signaling pathway. Yu H; Zhou C; Hu D; Li C; Wang Q; Xue W; Peng A Clin Exp Nephrol; 2022 Jul; 26(7):640-648. PubMed ID: 35333997 [TBL] [Abstract][Full Text] [Related]
2. The role of AMP-activated protein kinase α1-mediated endoplasmic reticulum stress in alleviating the toxic effect of uremic toxin indoxyl sulfate on vascular endothelial cells by Klotho. Chen C; Wu L; Xie C; Zhao X; Mao H; Xing C J Appl Toxicol; 2021 Sep; 41(9):1446-1455. PubMed ID: 33458837 [TBL] [Abstract][Full Text] [Related]
3. Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells. Shimizu H; Hirose Y; Goto S; Nishijima F; Zrelli H; Zghonda N; Niwa T; Miyazaki H Life Sci; 2012 Sep; 91(5-6):172-7. PubMed ID: 22781707 [TBL] [Abstract][Full Text] [Related]
4. Indoxyl sulfate promotes the atherosclerosis through up-regulating the miR-34a expression in endothelial cells and vascular smooth muscle cells in vitro. Li X; Lu Z; Zhou F; Jin W; Yang Y; Chen S; Xie Z; Zhao Y Vascul Pharmacol; 2020 Aug; 131():106763. PubMed ID: 32593718 [TBL] [Abstract][Full Text] [Related]
5. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review. Harlacher E; Wollenhaupt J; Baaten CCFMJ; Noels H Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008960 [TBL] [Abstract][Full Text] [Related]
6. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514 [TBL] [Abstract][Full Text] [Related]
7. Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K/Akt/NF-κB signaling pathway. He X; Jiang H; Gao F; Liang S; Wei M; Chen L Microsc Res Tech; 2019 Dec; 82(12):2000-2006. PubMed ID: 31448474 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia Promotes Human Umbilical Vein Smooth Muscle Cell Phenotypic Switching via the ERK 1/2/c-fos/NF-κB Signaling Pathway. Zhang W; Guo Z; Li L; Shi Z; Zhu T Ann Vasc Surg; 2022 Aug; 84():371-380. PubMed ID: 35405275 [TBL] [Abstract][Full Text] [Related]
9. Indoxyl sulfate counteracts endothelial effects of erythropoietin through suppression of Akt phosphorylation. Adelibieke Y; Shimizu H; Saito S; Mironova R; Niwa T Circ J; 2013; 77(5):1326-36. PubMed ID: 23337206 [TBL] [Abstract][Full Text] [Related]
10. Histopathological and proteomic analyses identify integrin-β1 as a potential mediator of phlebosclerosis in uremic patients. Zhou C; Li C; Wang Q; Wu M; Mohan C; Hu D; Peng A Clin Exp Nephrol; 2019 Sep; 23(9):1100-1108. PubMed ID: 31214872 [TBL] [Abstract][Full Text] [Related]
11. Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance. Daneshamouz S; Eduok U; Abdelrasoul A; Shoker A NanoImpact; 2021 Jan; 21():100299. PubMed ID: 35559786 [TBL] [Abstract][Full Text] [Related]
12. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis. Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425 [TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
14. [Research progress of the uremic toxin indoxyl sulfate in cardiovascular complication of end-stage renal diseases]. Guo CC; Xia WW; Zhang AH Sheng Li Xue Bao; 2018 Dec; 70(6):657-662. PubMed ID: 30560276 [TBL] [Abstract][Full Text] [Related]
15. Indoxyl sulfate enhances IL-1β-induced E-selectin expression in endothelial cells in acute kidney injury by the ROS/MAPKs/NFκB/AP-1 pathway. Shen WC; Liang CJ; Huang TM; Liu CW; Wang SH; Young GH; Tsai JS; Tseng YC; Peng YS; Wu VC; Chen YL Arch Toxicol; 2016 Nov; 90(11):2779-2792. PubMed ID: 26659566 [TBL] [Abstract][Full Text] [Related]
16. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins. Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233 [TBL] [Abstract][Full Text] [Related]
17. Indoxyl Sulfate-Induced Extracellular Vesicles Released from Endothelial Cells Stimulate Vascular Smooth Muscle Cell Proliferation by Inducing Transforming Growth Factor-Beta Production. Ryu JH; Jeon EY; Kim SJ J Vasc Res; 2019; 56(3):129-138. PubMed ID: 31085925 [TBL] [Abstract][Full Text] [Related]
18. The microbial metabolite p-cresol compromises the vascular barrier and induces endothelial cytotoxicity and inflammation in a 3D human vessel-on-a-chip. Mankhong S; Den-Udom T; Tanawattanasuntorn T; Suriyun T; Muta K; Kitiyakara C; Ketsawatsomkron P Sci Rep; 2024 Aug; 14(1):18553. PubMed ID: 39122790 [TBL] [Abstract][Full Text] [Related]
19. Uremic endothelial-derived extracellular vesicles: Mechanisms of formation and their role in cell adhesion, cell migration, inflammation, and oxidative stress. Favretto G; da Cunha RS; Flores Santos A; Leitolis A; Schiefer EM; Gregório PC; Franco CRC; Massy Z; Dalboni MA; Stinghen AEM Toxicol Lett; 2021 Sep; 347():12-22. PubMed ID: 33945863 [TBL] [Abstract][Full Text] [Related]